In this blog, we’re going to be sharing some of the methods we use at Reverie to develop the models and high performance systems that power drug development programs. But first, we want to talk a little bit about why we are doing this.
We started Reverie because millions of people die of cancer every single year. Cancer is a brutal, sinister disease and we pride ourselves on using our cross-disciplinary backgrounds to make headway against this grand challenge.
At Reverie, we are building a biotech company that drives decision-making with computation, and uses computational scale as a core asset to empower drug development. Yes, we recognize there is significant hype in “AI for X” these days, and we will do our part to stay away from that. Our objective with this blog is to show what works, why it works, and how to better inform decision-making with computation. We look forward to engaging with the broader scientific community in this process, since we are motivated by a shared goal: offering patients a new chance at life. We hope you’ll join us in achieving that.